본문 바로가기
KERD
논문KCI 등재

Bifidobacterium infantis Induces Protective Colonic PD-L1 and Foxp3 Regulatory T Cells in an Acute Murine Experimental Model of Inflammatory Bowel Disease

3

조회

0

다운로드

2

인용

0

참고문헌

키워드

초록

Background/Aims: The current study aims to investigate the protective effects of Bifidobacterium infantis on the abnormal immune response to inflammatory bowel disease (IBD) in dextran sodium sulfate (DSS)-induced colitis. Methods: Eight-week-old BALB/c mice were separated into five groups at random (control, DSS, DSS+B9 [B. infantis 1×109 CFU], DSS+B8 [B. infantis 1×108 CFU], and DSS+B7 [B. infantis 1×107 CFU]). Colitis was induced by 5% DSS ad libitum for 7 days, at which time we assessed weight, the disease activity index (DAI) score, and the histological damage score. The nuclear transcription factor Foxp3 (a marker of Treg cells), cytokines interleukin-10 (IL-10) and transforming growth factor β1 (TGF-β1), and related proteins (programmed cell death ligand 1 [PD-L1] and programmed cell death 1 [PD-1]) were detected by an immunohistochemical method and Western blot. Results: B. infantis increased weight, decreased DAI scores and histological damage scores, increased the protein expression of Foxp3 (p<0.05) and cytokines IL-10 and TGF-β1 in mouse colon tissue (p<0.05), and increased the expression of PD-L1 in the treatment groups relative to that in the DSS group (p<0.05). The effect of B. infantis on Foxp3 and PD-L1 was dose dependent in the treatment groups (p<0.05). PD-L1 was positively correlated with Foxp3, IL- 10, and TGF-β1. Conclusions: In a mouse model of IBD, B. infantis can alleviate intestinal epithelial injury and maintain intestinal immune tolerance and thus may have potential therapeutic value for the treatment of immune damage in IBD.

Abstract

Background/Aims: The current study aims to investigate the protective effects of Bifidobacterium infantis on the abnormal immune response to inflammatory bowel disease (IBD) in dextran sodium sulfate (DSS)-induced colitis. Methods: Eight-week-old BALB/c mice were separated into five groups at random (control, DSS, DSS+B9 [B. infantis 1×109 CFU], DSS+B8 [B. infantis 1×108 CFU], and DSS+B7 [B. infantis 1×107 CFU]). Colitis was induced by 5% DSS ad libitum for 7 days, at which time we assessed weight, the disease activity index (DAI) score, and the histological damage score. The nuclear transcription factor Foxp3 (a marker of Treg cells), cytokines interleukin-10 (IL-10) and transforming growth factor β1 (TGF-β1), and related proteins (programmed cell death ligand 1 [PD-L1] and programmed cell death 1 [PD-1]) were detected by an immunohistochemical method and Western blot. Results: B. infantis increased weight, decreased DAI scores and histological damage scores, increased the protein expression of Foxp3 (p<0.05) and cytokines IL-10 and TGF-β1 in mouse colon tissue (p<0.05), and increased the expression of PD-L1 in the treatment groups relative to that in the DSS group (p<0.05). The effect of B. infantis on Foxp3 and PD-L1 was dose dependent in the treatment groups (p<0.05). PD-L1 was positively correlated with Foxp3, IL- 10, and TGF-β1. Conclusions: In a mouse model of IBD, B. infantis can alleviate intestinal epithelial injury and maintain intestinal immune tolerance and thus may have potential therapeutic value for the treatment of immune damage in IBD.

참고문헌 (36)

  1. Kaplan GG, "The global burden of IBD : from 2015 to 2025", Nat Rev Gastroenterol Hepatol, 12, pp.720~727 (2015)
  2. Ng SC, "Incidence and phenotype of inflammatory bowel disease based on results from the Asiapacific Crohn’s and colitis epidemiology study", Gastroenterology, 145, pp.158~165 (2013)
  3. Sarrabayrouse G, "Microbiotaspecific CD4CD8 alphaplaha Tregs : role in intestinal immune homeostasis and implications for IBD", Front Immunol, 6, pp.522~ (2015)
  4. Maul J, "Peripheral and intestinal regulatory CD4+ CD25(high)T cells in inflammatory bowel disease", Gastroenterology, 128, pp.1868~1878 (2005)
  5. Kryczek I, "Inflammatory regulatory T cells in the microenvironments of ulcerative colitis and colon carcinoma", Oncoimmunology, 5, pp.e1105430~ (2016)
  6. Tripathi S, "Role of PD1", PDL1 pathway, and TH17 and Treg cells in maternal tolerance to the fetus, 2015, pp.38, 25~31
  7. Zuo L, "Bifidobacterium infantis attenuates colitis by regulating T cell subset responses", World J Gastroenterol, 20, pp.18316~18329 (2014)
  8. Fu L, "Bifidobacterium infantis potentially alleviates shrimp tropomyosin-induced allergy by tolerogenic dendritic cell-dependent induction of regulatory T cells and alterations in gut microbiota", Front Immunol, 8, pp.1536~ (2017)
  9. Hamamoto N, "Inhibition of dextran sulphate sodium(DSS)-induced colitis in mice by intracolonically administered antibodies against adhesion molecules(endothelial leucocyte adhesion molecule-1(ELAM-1)or intercellular adhesion molecule-1(ICAM-1))", Clin Exp Immunol, 117, pp.462~468 (1999)
  10. Dieleman LA, "Chronic experimental colitis induced by dextran sulphate sodium(DSS)is characterized by Th1 and Th2 cytokines", Clin Exp Immunol, 114, pp.385~391 (1998)
  11. Molodecky NA, "Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review", Gastroenterology, 142, pp.46~54 (2012)
  12. Round JL, "The gut microbiota shapes intestinal immune responses during health and disease", Nat Rev Immunol, 9, pp.313~323 (2009)
  13. Melgar S, "Validation of murine dextran sulfate sodium-induced colitis using four therapeuticagents for human inflammatory bowel disease", Int Immunopharmacol, 8, pp.836~844 (2008)
  14. Perše M, "Dextran sodium sulphate colitis mouse model : traps and tricks", J Biomed Biotechnol, 2012, pp.718617~ (2012)
  15. Håkansson Å, "Immunological alteration and changes of gut microbiota after dextran sulfate sodium(DSS)administration in mice", Clin Exp Med, 15, pp.107~120 (2015)
  16. Barba-Vidal E, "The probiotic combination of Bifidobacterium longum subsp. infantis CECT 7210 and Bifidobacterium animalis subsp. lactis BPL6 reduces pathogen loads and improves gut health of weaned piglets orally challenged with Salmonella Typhimurium", Front Microbiol, 8, pp.1570~ (2017)
  17. Giannetti E, "Probiotics for irritable bowel syndrome:clinical data in children", J Pediatr Gastroenterol Nutr, 63(Suppl 1), pp.S25~S26 (2016)
  18. van Herk EH, "Treg subsets in inflammatory bowel disease and colorectal carcinoma : characteristics, role, and therapeutic targets", J Gastroenterol Hepatol, 31, pp.1393~1404 (2016)
  19. 박진실, "Lactobacillus acidophilus Improves Intestinal Inflammation in an Acute Colitis Mouse Model by Regulation of Th17 and Treg Cell Balance and Fibrosis Development", Journal of Medicinal Food, 21(3), pp.215~224 (2018), 한국식품영양과학회[DOI]
  20. Izcue A, "Regulatory T cells suppress systemic and mucosal immune activation to control intestinal inflammation", Immunol Rev, 212, pp.256~271 (2006)
  21. Mottet C, "Cutting edge : cure of colitis by CD4+CD25+ regulatory T cells", J Immunol, 170, pp.3939~3943 (2003)
  22. Canavan JB, "Developing in vitro expanded CD45RA+ regulatory T cells as an adoptive cell therapy for Crohn’s disease", Gut, 65, pp.584~594 (2016)
  23. Williams LM, "Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3", Nat Immunol, 8, pp.277~284 (2007)
  24. Laidlaw BJ, "Production of IL-10 by CD4(+)regulatory T cells during the resolution of infection promotes the maturation of memory CD8(+)T cells", Nat Immunol, 16, pp.871~879 (2015)
  25. Rennick DM, "Lessons from genetically engineered animal models. XII. IL-10-deficient (IL-10(-", -) mice and intestinal inflammation, 2000, pp.278, G829~G833
  26. Tilg H, "Treatment of Crohn’s disease with recombinant human interleukin 10 induces the proinflammatory cytokine interferon gamma", Gut, 50, pp.191~195 (2002)
  27. Kitamura H, "Role of heat shock protein 47 in intestinal fibrosis of experimental colitis", Biochem Biophys Res Commun, 404, pp.599~604 (2011)
  28. Chowdhury A, "Growth factor mRNA expression in normal colorectal mucosa and in uninvolved mucosa from ulcerative colitis patients", J Gastroenterol, 31, pp.353~360 (1996)
  29. Zhao HM, "Probiotics increase T regulatory cells and reduce severity of experimental colitis in mice", World J Gastroenterol, 19, pp.742~749 (2013)
  30. Konieczna P, "Bifidobacterium infantis 35624 administration induces Foxp3 T regulatory cells in human peripheral blood : potential role for myeloid and plasmacytoid dendritic cells", Gut, 61, pp.354~366 (2012)
  31. Zheng B, "Bifidobacterium breve attenuates murine dextran sodium sulfateinduced colitis and increases regulatory T cell responses", PLoS One, 9, pp.e95441~ (2014)
  32. Zamani MR, "PD-1", PD-L and autoimmunity : a growing relationship, 2016, pp.310, 27~41
  33. Song MY, "Protective effects of Fc-fused PD-L1 on two different animal models of colitis", Gut, 64, pp.260~271 (2015)
  34. Barber DL, "Restoring function in exhausted CD8 T cells during chronic viral infection", Nature, 439, pp.682~687 (2006)
  35. Totsuka T, "Regulation of murine chronic colitis by CD4+CD25-programmed death-1+ T cells", Eur J Immunol, 35, pp.1773~1785 (2005)
  36. Francisco LM, "PD-L1 regulates the development, maintenance, and function of induced regulatory T cells", J Exp Med, 206, pp.3015~3029 (2009)

관련 논문AI추천

PD-1 deficiency protects experimental colitis via alteration of gut microbiota김지혜, 박성정, 박윤지, 성영철, 송미영, 이승우생화학분자생물학회 · BMB Reports2017 · 제50권 제11호Synbiotic of Pediococcus acidilactici and Inulin Ameliorates Dextran Sulfate Sodium-Induced Acute Ulcerative Colitis in MiceCui Chengdu, Cui Lianhua, Jin Xin, Jin Yuanming, Piao Huiyan, Wang Mingzhu, Yan Chunri, Zhang Longzhou한국미생물·생명공학회 · Journal of Microbiology and Biotechnology2024 · 제34권 제3호The role of PD-1/PD-L1 pathway in ulcerative colitis and changes following tonsil-derived mesenchymal stem cells treatment김성은, 송은미, A-Reum Choe, Chang Mo Moon, Chung Hyun Tae, Hye-Kyung Jung, Ju-Ran Byeon, Ki-Nam Shim, Sung-Ae Jung, Yang Hee Joo, Yehyun Park대한내과학회 · The Korean Journal of Internal Medicine2024 · 제39권 제6호Lactic Acid Bacteria Isolated from Human Breast Milk Improve Colitis Induced by 2,4,6-Trinitrobenzene Sulfonic Acid by Inhibiting NF-κB Signaling in Mice장세은, Im Minju, Jin Hui, Kim Hyun Su, Kim Jae-won, Kim Kyung-Joo, Kyung Suhyun한국미생물·생명공학회 · Journal of Microbiology and Biotechnology2023 · 제33권 제8호Latilactobacillus curvatus BYB3 Isolated from Kimchi Alleviates Dextran Sulfate Sodium (DSS)-Induced Colitis in Mice by Inhibiting IL-6 and TNF-R1 Production오세종, Kim Kiyeop, Li Dingyun, Meng Ziyao, Wang Xing한국미생물·생명공학회 · Journal of Microbiology and Biotechnology2022 · 제32권 제3호Protective Potential of Limosilactobacillus fermentum Strains and Their Mixture on Inflammatory Bowel Disease via Regulating Gut Microbiota in MiceChoi Kayoung, Joung Jae Yeon, Lee Ju-Hoon, Oh Nam Su한국미생물·생명공학회 · Journal of Microbiology and Biotechnology2025 · 제35권

이 간행물의 다른 논문 (13건)